Syner-G BioPharma Group (Riverside Partners) Acquires RMC Pharmaceutical Solutions

Riverside Partners Invests in Syner-G Pharma Consulting

October 29, 2020

Healthcare Services

Riverside Partners, a Boston-based private equity firm, completed an investment in Syner-G Pharma Consulting, a CMC regulatory and compliance consulting firm headquartered in Southborough, Massachusetts. The partnership with Syner-G's founders aims to support the company's next stage of growth, expand customer reach, and broaden service offerings to pharmaceutical and biotechnology clients.

Riverside Partners Combines Sequoia Biotech Consulting and Syner-G BioPharma Group

September 18, 2024

Healthcare Services

Boston-based private equity firm Riverside Partners has combined two of its portfolio companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, into a single, integrated life‑sciences services business. The combined organization — bringing together regulatory, development, quality, and operational capabilities — has approximately 500 employees and will provide end-to-end solutions to pharmaceutical, biotechnology, and medical device clients.

Syner-G Acquires Impact Pharmaceutical Services

February 1, 2022

Healthcare Services

Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired Impact Pharmaceutical Services, a Research Triangle Park-based provider of medical writing, regulatory strategy, and regulatory publishing services for biotech and pharmaceutical clients. The deal, which closed in late December, expands Syner-G's CMC and regulatory capabilities to better support clients across pre-IND through post-marketing stages; financial terms were not disclosed.

R1 RCM Acquires SCI Solutions

April 1, 2020

Healthcare Services

R1 RCM Inc. completed the acquisition of SCI Solutions, a provider of digital patient access and engagement software, to expand its technology-enabled revenue cycle and patient intake capabilities. The deal (announced Jan 2020, closed Apr 2020) brings SCI’s EHR-agnostic care coordination marketplace and digital “front door” offerings into R1’s platform, and was previously owned by investors including The Wicks Group, NEA and Columbia Pacific.

Red Nucleus (RN) / Riverside Acquire AlphaGroup Medical Communications

December 12, 2022

Healthcare Services

Red Nucleus (RN), a portfolio company of The Riverside Company, has acquired AlphaGroup Medical Communications, LLC as an add-on to RN's medical communications business unit. The acquisition expands RN's publications, medical affairs and HEOR/RWE capabilities and brings AlphaGroup's therapeutic expertise and scientific staff into the combined business.

Red Nucleus Acquires Medical Marketing Solutions Group (MMSG)

February 9, 2022

Healthcare Services

Red Nucleus, a Riverside-backed medical communications and scientific services provider, acquired Medical Marketing Solutions Group (MMSG) in February 2022 to expand its medical communications, publication planning, and conference management capabilities. The acquisition was completed as an add-on to the Red Nucleus platform, owned by The Riverside Company, broadening Red Nucleus’s therapeutic-area coverage and client relationships within biopharma.